'Changing the whole game of drug discovery': Legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO
Roger Perlmutter needs no introduction to anyone remotely involved in biopharma. As the R&D chief first at Amgen and then Merck, he’s built a stellar …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
